n this release
should be read in conjunction with the consolidated financial statements and
notes thereto included in our public filings with the Securities and Exchange
Commission. For a discussion of other important factors that could adversely
affect our business, financial condition, results of operations and prospects,
see "Risk Factors" beginning on page 5 of our annual report on Form 20-F,
filed on June 30, 2008. Our results of operations for the fourth quarter of
2008 and for fiscal year 2008 are not necessarily indicative of our operating
results for any future periods. Any projections in this release are based on
limited information currently available to us, which is subject to change.
Although such projections and the factors influencing them will likely change,
we will not necessarily update the information. Such information speaks only
as of the date of this release.
All references to "shares" are to our ordinary shares, which are divided
into two classes, Class A and Class B. Each of our American Depositary Shares,
which trade on the New York Stock Exchange, represents one Class A ordinary
Mindray is a leading developer, manufacturer and marketer of medical
devices worldwide. Established in 1991, Mindray offers a broad range of
products across three primary business segments: patient monitoring & life
support products, in-vitro diagnostic products and medical imaging systems.
Mindray is globally headquartered in Shenzhen, China, with U.S. headquarters
in Mahwah, New Jersey. Mindray also has another 12 international sales and
service offices in Amsterdam, Frankfurt, Istanbul, London, Mexico City, Moscow,
Mumbai, Paris, Sao Paolo, Seattle, Toronto and Vancouver. For more information,
please visit http://www.mindray.com .
MINDRAY MEDICAL INTERNATIONAL LIMITED
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Related biology technology :1
|SOURCE Mindray Medical International Limited|
Copyright©2009 PR Newswire.
All rights reserved
. Mindray Medical International Announces Second Quarter 2008 Results2
. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference3
. Mindray Medical International Announces First Quarter 2008 Results4
. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million5
. Mindray Medical International Announces Third Quarter 2007 Results6
. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director7
. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference8
. Martek Announces First Quarter 2009 Financial Results9
. Quest PharmaTech Announces Results Showing its Photosensitizer, SL052, is an Effective Immuno-Stimulant when combined with Immunotherapy for the Removal of Solid Tumors10
. STAAR Surgical Announces Fourth Quarter and Full Year 2008 Earnings Release Date and Conference Call11
. Oncothyreon announces webcast of fourth quarter and year end 2008 financial results conference call